In July 2011, OHE launched its publication, New drugs to tackle antimicrobial resistance, and also hosted a roundtable with a number of stakeholders. The objective of the roundtable was to create a consensus about the critical issues in constructing a framework that can encourage antibacterial R&D, identify potential obstacles to implementation, and consider how best to move forward. This publication recounts the discussions during both sessions.
Please note: this item requires free registration in order to access it.